Balasubramanyam, M (2014) Metformin: Nature’s Gift that Keeps on Giving More. Journal of Obesity and Metabolic Research, 1 (2). p. 118.
| PDF 373Kb |
Abstract
Despite many different drugs being available for type 2 diabetes, metformin remains a cornerstone in the management of diabetes. In a consensus statement, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend metformin as the first step in the treatment type 2 diabetes, in the absence of drug contraindications.[1] Thus, worldwide, metformin is now the unanimous first‑line glucose‑lowering agent. While several recent antidiabetic drugs have been under the cloud, some being withdrawn, others asked to give warnings in labels and a few still under strict Food and Drug Administration (FDA) scrutiny, metformin, a time‑tested drug, has surpassed the hurdles and become the most prescribed medicine in diabetes and other conditions of insulin resistance. Why is there now a “metformin wave” everywhere? Here, we will discuss this “metformin paradox” of an old wine in a new bottle.
| Item Type: | Article |
|---|---|
| Official URL/DOI: | http://mdrf.in/ |
| Uncontrolled Keywords: | Metformin |
| Subjects: | Biochemistry,Cell and Molecular Signalling |
| Divisions: | Department of Advanced Research Biochemistry |
| ID Code: | 874 |
| Deposited By: | surendar radha |
| Deposited On: | 06 Nov 2014 15:52 |
| Last Modified: | 06 Nov 2014 15:52 |
Repository Staff Only: item control page

